#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrous dysplasia of bone Thrombotic thrombocytopenic purpura Cardiac failure acute Renal transplant Myotonic dystrophy Myasthenia gravis Gastrointestinal disorder Retinopathy of prematurity Osteosarcoma metastatic Progressive supranuclear palsy Small intestine leiomyosarcoma Primary hyperoxaluria Squamous cell carcinoma of the oral cavity Pancreatic carcinoma metastatic Familial haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Basic Information Familial haemophagocytic lymphohistiocytosis – Trials in Disease Pulmonary fibrosis – Life with Disease Glycogen storage disease type II – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Progressive supranuclear palsy – Basic Information Basal cell naevus syndrome SAPHO syndrome – Life with Disease Angiosarcoma metastatic Skin angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adrenaline Acid Tartrate Bp Tipiracil Phenprocoumon Censavudine Lisdexamfetamine Dimesylate Sunitinib Bisoprolol Dog Epithelia Cefotaxime Sapropterin Dihydrochloride Interleukin-2 Dexrazoxane Gns561 ROPINIROLE VIPOGLANSTAT IMB 101 XENON (133XE) Paroxetine Sym024 Pyridoxine More therapies…

    Learn about Your Condition

    Systemic infection Anaemia of chronic disease Mumps Malignant neoplasm of choroid Thrombectomy Acarodermatitis White matter lesion Immune-mediated renal disorder Knee arthroplasty Syphilis Deafness bilateral B-cell lymphoma refractory Alport's syndrome ROHHAD syndrome Developmental hip dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Warminsko-Mazurskie Centrum Chorob Pluc W Olsztynie…

Warminsko-Mazurskie Centrum Chorob Pluc W Olsztynie

Ul. Jagiellonska Nr 78, Olsztyn, 10-357, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Axatilimab
    Belgium Czechia France Germany Italy Poland +2

  • Study of Pembrolizumab, Olaparib, and Pemetrexed for Patients with Stage IV Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Olaparib
    • Carboplatin
    • Cisplatin
    Austria France Germany Poland Romania Spain

  • Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Nivolumab
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Placebo
    • Carboplatin
    • Cisplatin
    Austria Bulgaria France Germany Italy Poland +1

  • Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer
    Austria Belgium France Germany Greece Hungary +6

  • Study of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaplastic lymphoma kinase gene mutation
    • Non-small cell lung cancer
    Investigated Drugs:
    • Alectinib
    • Vinorelbine
    • Carboplatin
    Austria Denmark France Germany Greece Hungary +4

  • Study on Vudalimab or Pembrolizumab with Chemotherapy for Advanced Non-small Cell Lung Cancer Patients

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Vudalimab
    • Carboplatin
    • Pembrolizumab
    Belgium Greece The Netherlands Poland Portugal Romania +1

  • Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Austria Bulgaria France Germany Greece Hungary +4

  • Study of Tiragolumab, Atezolizumab, and Pembrolizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Atezolizumab
    • Pembrolizumab
    • Tiragolumab
    Belgium Denmark France Germany Poland Spain

  • Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Belgium France Germany Italy Poland Spain
Previous Page
1 … 4 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!